LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Article ; Online: Trends in Incident Dementia Diagnosis Before and After Medicare Risk Adjustment.

    Zissimopoulos, Julie M / Joyce, Geoffrey F / Jacobson, Mireille

    JAMA network open

    2023  Volume 6, Issue 12, Page(s) e2347708

    MeSH term(s) Aged ; United States/epidemiology ; Humans ; Medicare ; Risk Adjustment ; Dementia/diagnosis ; Dementia/epidemiology
    Language English
    Publishing date 2023-12-01
    Publishing country United States
    Document type Journal Article
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2023.47708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia.

    Thunell, Johanna A / Joyce, Geoffrey F / Ferido, Patricia M / Chen, Yi / Guadamuz, Jenny S / Qato, Dima M / Zissimopoulos, Julie M

    Journal of Alzheimer's disease : JAD

    2024  

    Abstract: Background: Behavioral and psychological symptoms of dementia (BPSD) and prescribed central nervous system (CNS) active drugs to treat them are prevalent among persons living with Alzheimer's disease and related dementias (PLWD) and lead to negative ... ...

    Abstract Background: Behavioral and psychological symptoms of dementia (BPSD) and prescribed central nervous system (CNS) active drugs to treat them are prevalent among persons living with Alzheimer's disease and related dementias (PLWD) and lead to negative outcomes for PLWD and their caregivers. Yet, little is known about racial/ethnic disparities in diagnosis and use of drugs to treat BPSD.
    Objective: Quantify racial/ethnic disparities in BPSD diagnoses and CNS-active drug use among community-dwelling PLWD.
    Methods: We used a retrospective cohort of community-dwelling Medicare Fee-for-Service beneficiaries with dementia, continuously enrolled in Parts A, B and D, 2017-2019. Multivariate logistic models estimated rates of BPSD diagnosis and, conditional on diagnosis, CNS-active drug use.
    Results: Among PLWD, 67.1% had diagnoses of an affective, psychosis or hyperactivity symptom. White (68.3%) and Hispanic (63.9%) PLWD were most likely, Blacks (56.6%) and Asians (52.7%) least likely, to have diagnoses. Among PLWD with BPSD diagnoses, 78.6% took a CNS-active drug. Use was highest among whites (79.3%) and Hispanics (76.2%) and lowest among Blacks (70.8%) and Asians (69.3%). Racial/ethnic differences in affective disorders were pronounced, 56.8% of white PLWD diagnosed; Asians had the lowest rates (37.8%). Similar differences were found in use of antidepressants.
    Conclusions: BPSD diagnoses and CNS-active drug use were common in our study. Lower rates of BPSD diagnoses in non-white compared to white populations may indicate underdiagnosis in clinical settings of treatable conditions. Clinicians' review of prescriptions in this population to reduce poor outcomes is important as is informing care partners on the risks/benefits of using CNS-active drugs.
    Language English
    Publishing date 2024-04-26
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-231266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Understanding Primary Nonadherence.

    Joyce, Geoffrey F

    The American journal of pharmacy benefits

    2013  Volume 2, Issue 2, Page(s) 111–118

    Language English
    Publishing date 2013-12-01
    Publishing country United States
    Document type Journal Article
    ISSN 1945-4481
    ISSN 1945-4481
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Value of Elderly Disease Prevention.

    Goldman, Dana P / Cutler, David M / Shang, Baoping / Joyce, Geoffrey F

    Forum for health economics & policy

    2019  Volume 9, Issue 2

    Abstract: Approximately 100 million elderly will enter Medicare over the next 25 years. We consider the potential benefits of interventions that would reduce or eliminate the most important risk factors for disease and spending. Effective control of hypertension ... ...

    Abstract Approximately 100 million elderly will enter Medicare over the next 25 years. We consider the potential benefits of interventions that would reduce or eliminate the most important risk factors for disease and spending. Effective control of hypertension could reduce health care spending $890 billion for these cohorts while adding 75 million disability-adjusted life years (DALYs). Eliminating diabetes would add 90 million life-year equivalents at a cost of $2,761 per DALY. Reducing obesity back to levels seen in the 1980's would have little effect on mortality, but yields great improvements in morbidity (especially heart disease and diabetes) with a cost savings of over $1 trillion. Smoking cessation will have the smallest impact, adding 32 million DALYs at a cost of $9.045 per DALY. While smoking cessation reduces lung disease and lung cancer, but these are relatively low prevalence compared to the other diseases. Its impact on heart disease is negligible. The effects on overall social welfare are unknown, since we do not estimate the costs of these interventions, the costs of any behavioral modification, or the welfare loss due to providers from lower medical spending.
    Language English
    Publishing date 2019-02-18
    Publishing country Germany
    Document type Journal Article
    ISSN 1558-9544
    ISSN (online) 1558-9544
    DOI 10.2202/1558-9544.1004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Who Pays in Medicare Part D? Giving Plans More Skin in the Game.

    Trish, Erin E / Ginsburg, Paul B / Joyce, Geoffrey F / Goldman, Dana P

    The New England journal of medicine

    2019  Volume 381, Issue 25, Page(s) 2384–2387

    MeSH term(s) Cost Sharing ; Government Regulation ; Health Expenditures ; Insurance Coverage/legislation & jurisprudence ; Medicare Part D/economics ; Medicare Part D/legislation & jurisprudence ; Prescription Fees ; Private Sector ; United States
    Language English
    Publishing date 2019-11-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMp1912357
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Part D Formulary and Benefit Design as a Risk-Steering Mechanism.

    Goldman, Dana P / Joyce, Geoffrey F / Vogt, William B

    The American economic review

    2014  Volume 101, Issue 3, Page(s) 382–386

    MeSH term(s) Aged ; Cost Sharing ; Formularies as Topic ; Humans ; Insurance Selection Bias ; Medicare Part D ; Risk ; United States
    Language English
    Publishing date 2014-07-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2009979-4
    ISSN 1944-7981 ; 0002-8282
    ISSN (online) 1944-7981
    ISSN 0002-8282
    DOI 10.1257/aer.101.3.382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Did Medicare Part D reduce disparities?

    Zissimopoulos, Julie / Joyce, Geoffrey F / Scarpati, Lauren M / Goldman, Dana P

    The American journal of managed care

    2015  Volume 21, Issue 2, Page(s) 119–128

    Abstract: Objectives: We assessed whether Medicare Part D reduced disparities in access to medication.: Study design: Secondary data analysis of a 20% sample of Medicare beneficiaries, using Parts A and B medical claims from 2002 to 2008 and Part D drug claims ...

    Abstract Objectives: We assessed whether Medicare Part D reduced disparities in access to medication.
    Study design: Secondary data analysis of a 20% sample of Medicare beneficiaries, using Parts A and B medical claims from 2002 to 2008 and Part D drug claims from 2006 to 2008.
    Methods: We analyzed the medication use of Hispanic, black, and white beneficiaries with diabetes before and after reaching the Part D coverage gap, and compared their use with that of race-specific reference groups not exposed to the loss in coverage. Unadjusted difference-in-difference results were validated with multivariate regression models adjusted for demographics, comorbidities, and zip code-level household income used as a proxy for socioeconomic status.
    Results: The rate at which Hispanics reduced use of diabetes-related medications in the coverage gap was twice as high as whites, while blacks decreased their use of diabetes-related medications by 33% more than whites. The reduction in medication use was correlated with drug price. Hispanics and blacks were more likely than whites to discontinue a therapy after reaching the coverage gap but more likely to resume once coverage restarted. Hispanics without subsidies and living in low-income areas reduced medication use more than similar blacks and whites in the coverage gap.
    Conclusions: We found that the Part D coverage gap is particularly disruptive to minorities and those living in low-income areas. The implications of this work suggest that protecting the health of vulnerable groups requires more than premium subsidies. Patient education may be a first step, but more substantive improvements in adherence may require changes in healthcare delivery.
    MeSH term(s) African Americans/statistics & numerical data ; Aged ; Databases, Factual ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/economics ; European Continental Ancestry Group/statistics & numerical data ; Female ; Healthcare Disparities/ethnology ; Healthcare Disparities/statistics & numerical data ; Hispanic Americans/statistics & numerical data ; Humans ; Hypoglycemic Agents/economics ; Hypoglycemic Agents/therapeutic use ; Male ; Medicare Part D/economics ; Medicare Part D/statistics & numerical data ; Medication Adherence/ethnology ; Medication Adherence/statistics & numerical data ; Multivariate Analysis ; Poverty ; Regression Analysis ; Retrospective Studies ; Risk Assessment ; United States
    Chemical Substances Hypoglycemic Agents
    Language English
    Publishing date 2015-02
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2035781-3
    ISSN 1936-2692 ; 1088-0224 ; 1096-1860
    ISSN (online) 1936-2692
    ISSN 1088-0224 ; 1096-1860
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Digesting the doughnut hole.

    Joyce, Geoffrey F / Zissimopoulos, Julie / Goldman, Dana P

    Journal of health economics

    2013  Volume 32, Issue 6, Page(s) 1345–1355

    Abstract: Despite its success, Medicare Part D has been widely criticized for the gap in coverage, the so-called "doughnut hole". We compare the use of prescription drugs among beneficiaries subject to the coverage gap with usage among beneficiaries who are not ... ...

    Abstract Despite its success, Medicare Part D has been widely criticized for the gap in coverage, the so-called "doughnut hole". We compare the use of prescription drugs among beneficiaries subject to the coverage gap with usage among beneficiaries who are not exposed to it. We find that the coverage gap does, indeed, disrupt the use of prescription drugs among seniors with diabetes. But the declines in usage are modest and concentrated among higher cost, brand-name medications. Demand for high cost medications such as antipsychotics, antiasthmatics, and drugs of the central nervous system decline by 8-18% in the coverage gap, while use of lower cost medications with high generic penetration such as beta blockers, ACE inhibitors and antidepressants decline by 3-5% after reaching the gap. More importantly, lower adherence to medications is not associated with increases in medical service use.
    MeSH term(s) Aged ; Choice Behavior ; Drug Costs ; Empirical Research ; Female ; Humans ; Insurance Coverage/economics ; Insurance Coverage/legislation & jurisprudence ; Male ; Medicare Part D/economics ; Medicare Part D/organization & administration ; Medication Adherence ; Prescription Drugs/economics ; Prescription Drugs/therapeutic use ; United States
    Chemical Substances Prescription Drugs
    Language English
    Publishing date 2013-05-06
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 625797-5
    ISSN 1879-1646 ; 0167-6296
    ISSN (online) 1879-1646
    ISSN 0167-6296
    DOI 10.1016/j.jhealeco.2013.04.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Digesting the doughnut hole

    Joyce, Geoffrey F / Zissimopoulos, Julie / Goldman, Dana P

    Journal of health economics. 2013 Dec., v. 32, no. 6

    2013  

    Abstract: Despite its success, Medicare Part D has been widely criticized for the gap in coverage, the so-called “doughnut hole”. We compare the use of prescription drugs among beneficiaries subject to the coverage gap with usage among beneficiaries who are not ... ...

    Abstract Despite its success, Medicare Part D has been widely criticized for the gap in coverage, the so-called “doughnut hole”. We compare the use of prescription drugs among beneficiaries subject to the coverage gap with usage among beneficiaries who are not exposed to it. We find that the coverage gap does, indeed, disrupt the use of prescription drugs among seniors with diabetes. But the declines in usage are modest and concentrated among higher cost, brand-name medications. Demand for high cost medications such as antipsychotics, antiasthmatics, and drugs of the central nervous system decline by 8–18% in the coverage gap, while use of lower cost medications with high generic penetration such as beta blockers, ACE inhibitors and antidepressants decline by 3–5% after reaching the gap. More importantly, lower adherence to medications is not associated with increases in medical service use.
    Keywords angiotensin-converting enzyme inhibitors ; antidepressants ; antipsychotics ; central nervous system ; diabetes ; doughnuts
    Language English
    Dates of publication 2013-12
    Size p. 1345-1355.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 625797-5
    ISSN 1879-1646 ; 0167-6296
    ISSN (online) 1879-1646
    ISSN 0167-6296
    DOI 10.1016/j.jhealeco.2013.04.007
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Digesting the doughnut hole

    Joyce, Geoffrey F / Goldman, Dana P / Zissimopoulos, Julie

    Journal of health economics Vol. 32, No. 6 , p. 1345-1355

    2013  Volume 32, Issue 6, Page(s) 1345–1355

    Author's details Geoffrey F. Joyce; Julie Zissimopoulos; Dana P. Goldman
    Keywords Medicare Part D ; Coverage gap ; Prescription Drugs ; Insurance Design ; Price Elasticity
    Language English
    Size graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam [u.a.]
    Document type Article
    ZDB-ID 625797-5
    ISSN 1879-1646 ; 0167-6296
    ISSN (online) 1879-1646
    ISSN 0167-6296
    Database ECONomics Information System

    More links

    Kategorien

To top